☆ 4.7 Editorial Material

CDK4/6 inhibition in early-stage breast cancer: how far is it from becoming standard of care?

LANCET ONCOLOGY (2021)

Journal

LANCET ONCOLOGY

Volume 22, Issue 2, Pages 159-160

Publisher

ELSEVIER SCIENCE INC

DOI: 10.1016/S1470-2045(20)30757-9

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.